摘要
勃起功能障碍(erectile dysfunction,ED)是男性常见疾病,直接影响患者及其配偶的生活质量。PDE5抑制剂是治疗ED的首选药物。尽管临床主要有3种PDE5抑制剂(西地那非、伐地那非和他达拉非)可供选择,但是患者及其配偶在选择PDE5抑制剂上是否有偏好,以及影响其选择的因素又有哪些本文简要地综述了最近的研究进展。
Erectile Dysfunction（ED）is a common male diseases which directly affects the life quality of the patients and their partners.Phosphodiesterase 5（PDE5）inhibitors are the first choice among the drugs for the treatment of ED.Nowadays,3 types of PDE5 inhibitors（Sildenafil,vardenafil and tadalafil）are commonly used in clinic at practice.But which is preferred by ED patients and their partners and what are the potential reasons for their preference？
出处
《中华男科学杂志》
CAS
CSCD
2008年第7期665-668,共4页
National Journal of Andrology
